🇺🇸 White House vs. Anthropic: The Mythos AI Standoff

A growing dispute between the White House and Anthropic is exposing a deeper issue in the AI race: who gets access to the most powerful models — and when.

At the center of the debate is Anthropic’s advanced AI system, Mythos, and a proposed expansion that would significantly increase private-sector access.

https://images.openai.com/static-rsc-4/SyJMouZcz0033VjO2fdICOJITdPmTbl8EmuLa7BwbpkUDap1dopYLgknpGPhjLRf1x0v-pbpn-_4kPJ4ezqzKAwQzNRQ9OIE8sS5Bgg4cCvfXL9sOp930qkMZc-uAomvhQeMPgrLKSIUTl0GMwUR0qaMDC8QKXpC828ohi3VHkeHPrHEjd4PPf5198xKEea4?purpose=fullsize
https://images.openai.com/static-rsc-4/UKD0D78L5wDWrxvZ27Bv2JqIFm8c3Vw9KEOxdNahS1OEWVYL3kKhbnSv4dl-j-Q-mDv1KDePZflSwmsz8yB25DPqRNcfvIeNJL2sbzq8bM5h6fzwS9pLhnNnf1ySK-boeD6s2kH2KQCS037_0607NorqlkR9RZFbmOkoPXFDXBE9rOef63SUXlhA4RutVSwJ?purpose=fullsize
https://images.openai.com/static-rsc-4/qOdX9pSI3xphTvSGAaYzwV1oQq-Kze6fAP40TzASczOIesTT7E5O4c4YlGETKkTbaUus3WDoHd53Xc0rH8IyeVOU5BEPdLbh0-cv_5moIKkOqmZ7RXihFqu75OrzczYDHPzczD7YJ6pDjzKf8-X2MDj6WE3C_tfJ-9LQSCYh0AEy8JbinVQMO59JOOO2iCWp?purpose=fullsize

🔍 What’s Happening

Anthropic had plans to expand Mythos access from roughly 50 companies to nearly 120. On paper, it looks like a typical scale-up move. In practice, it triggered concern inside the U.S. government.

Officials pushed back, citing compute constraints — the fear that expanding access could strain infrastructure and limit availability for federal use, particularly in sensitive domains tied to defense and intelligence.

This friction comes as a new AI policy memo from the White House is being finalized — one that could reshape how agencies adopt and procure AI systems.


🧠 Policy Shift: Multi-Vendor AI Strategy

The upcoming memo is expected to encourage multi-vendor AI adoption across federal agencies, reducing reliance on any single provider.

This is a notable shift.

It also reportedly includes provisions that would allow agencies to bypass certain supply chain risk classifications, a move that could ease tensions with companies like Anthropic — even as legal and strategic disagreements continue.

In short: the government wants flexibility, redundancy, and leverage.


⚔️ Internal Friction in Washington

The situation isn’t just a government vs. company issue — there’s also disagreement within Washington.

Comments from figures like Pete Hegseth highlight a harder stance toward Anthropic, while others appear more focused on ensuring continued access to frontier AI capabilities.

This reflects a broader split:

  • One side prioritizes control, risk mitigation, and ideological scrutiny
  • The other prioritizes access, capability, and strategic advantage

🤖 The Bigger Picture: AI Parity Is Coming Fast

Adding urgency to the situation, models like GPT-5.5 are reportedly approaching similar cyber and reasoning capabilities as Mythos.

Former AI policy lead David Sacks suggested that most frontier models could reach comparable capability levels within six months.

If that timeline holds, exclusivity becomes temporary — and the battle shifts from who has access to how widely it’s deployed.


⚠️ Why It Matters

This isn’t just a policy disagreement — it’s a preview of how AI power will be managed:

  • Compute is now a strategic resource, not just a technical constraint
  • Access to frontier models is becoming a geopolitical lever
  • Government and private sector priorities are increasingly misaligned

The White House appears to be recalibrating — not necessarily backing away from Anthropic, but ensuring it doesn’t become dependent on any single player.

At the same time, internal divisions suggest that the U.S. is still figuring out how to balance innovation, control, and national security in the AI era.


If you zoom out, the signal is clear:
AI isn’t just a technology race anymore — it’s an infrastructure, policy, and power struggle all at once.

https://www.wsj.com/tech/ai/white-house-opposes-anthropics-plan-to-expand-access-to-mythos-model-dc281ab5

Biohub Bets $500M on “Virtual Biology” to Teach AI How Cells Behave

The push to scale AI beyond text and images is heading straight into biology—and the stakes couldn’t be higher.

https://images.openai.com/static-rsc-4/esGFaIJb80Q_BNGpDqbQvRuF6aQxhL9FPPPDZQ3MYc67iK8zkYDJiHWZdQY8CobdNpejg5eQdHyCSVH0omcpxKWlqstYT1OS_ooqtBmHRqO4lk_bwKx5ynU_JuhXkrNBjGd8BamfwCh5P55SsPn1cD09YoQV8FHuPBHfdaA3zG0qW0i2VVY6l9Y-cDDRwwf8?purpose=fullsize
https://images.openai.com/static-rsc-4/387H7dq7GRK1xS1zFbol6ym1Q3WQ-RQHR31XmkfcWdUpqXT8SJU50MgVaYWAfibxYJH-8o55h6H-GocwXZLR6GWFc6MWVpw9x1ylh70SzF1jUzub2FlxS5ULeKzpiONZErKJoAX81BiCQPBKDptmRUucD70gAYQDEWk_7CKbXyIc9K0GPpEEkK27UyOMNStp?purpose=fullsize
https://images.openai.com/static-rsc-4/kVCDcjbRQ83e8msDlUEYyuvpTxKcCoVqUiz0TFm2UmhO9i33vWYt_vh0Ds6awEitcoeUjgtYYIUS29oEQ90NlrGZDdG8qd18gqn2iwLCFcw4brmvW9NhdBpKqOYd-sxo_4S1vNIdvz3Ehd6iBVuG3_XhGpX1w1WCFMFtVCzUxEAuDaU98_QwHIjH4z9dVWkz?purpose=fullsize

Backed by Mark Zuckerberg and Priscilla Chan, the Chan Zuckerberg Initiative’s Biohub has announced a $500M Virtual Biology Initiative aimed at building massive, open datasets and models that can predict how human cells behave.

The Big Bet: Data First, Models Second

The initiative is structured around a simple but ambitious premise: biology needs better data before AI can truly transform it.

  • $400M is earmarked for large-scale data generation and advanced imaging technologies
  • $100M will support external labs and collaborative research
  • Partners include organizations like Nvidia and the Allen Institute

Biohub is also committing to open datasets, positioning this as shared infrastructure rather than a closed, proprietary race.

Why This Matters: Biology Isn’t Language

Today’s AI breakthroughs were fueled by internet-scale data. Biology isn’t there yet.

Current datasets top out around ~1 billion cells, but researchers like Alex Rives argue we need an order of magnitude more to unlock meaningful predictive power. The goal isn’t just classification—it’s simulation:

  • Predict how cells respond to drugs
  • Understand disease progression at a molecular level
  • Eventually reprogram biological systems

That’s a leap from analyzing biology → to modeling and controlling it.

The Long-Term Vision

The ambition aligns with ideas from leaders like Demis Hassabis, who has suggested AI could one day help eliminate disease entirely.

Biohub’s approach is essentially:

Build the dataset → train the models → simulate biology → intervene with precision

The Real Question

We’ve seen scaling laws transform language models and protein folding. But biology is messier, noisier, and far less standardized.

Will scaling data unlock cellular intelligence the same way it unlocked GPT-level reasoning?
Or does biology require fundamentally new paradigms beyond brute-force scale?

Bottom Line

Biohub isn’t just funding research—it’s attempting to build the foundational data layer for AI-driven biology.

If it works, this could mark the shift from AI as a tool for discovery…
to AI as a system for designing and controlling life at the cellular level.

https://biohub.org/news/virtual-biology-initiative